Reckoning with our Mistakes
By Jen Schwartz and Dan Schlenoff,
Scientific American
| 08. 19. 2020
An article about women engineers, published in 1908, has a promising start: If women are attending technical schools and are not legally blocked from working in a forge or firm, why do they face so many obstacles to employment? A reader in 2020 who discovers such a socially progressive question in the archives of Scientific American anticipates a discussion of sex discrimination. Perhaps women such as Emily Warren Roebling, who took over her husband's role as chief engineer on construction of the Brooklyn Bridge after he became bedridden, will be held up for their contributions to the field. Surely the article will feature the voice of Nora Stanton Barney, who had recently fought to become the first woman accepted as a junior member in the American Society of Civil Engineers and was active in the suffrage movement.
Alas, no. Author Karl Drews explains it simply: the obstacles “are inherent in the nature of the case and are due to women's comparative weakness, both bodily and mental.” He elaborates: “The work of the engineer is creative in the highest sense of...
Related Articles
Since the “CRISPR babies” scandal in 2018, no additional genetically modified babies are known to have been born. Now several techno-enthusiastic billionaires are setting up privately funded companies to genetically edit human embryos, with the explicit intention of creating genetically modified children.
Heritable genome editing remains prohibited by policies in the overwhelming majority of countries that have any relevant policy, and by a binding European treaty. Support for keeping it legally off limits is widespread, including among scientists...
By Sophie Alexander and Ike Swetlitz, Bloomberg | 06.25.2025
A California-startup focused on genetically editing human embryos — a step toward creating so-called designer babies — is raising money as many of Silicon Valley’s ultra-rich turn their attention to one of the most controversial technologies in medicine.
Bootstrap Bio...
By Ed Cara, Gizmodo | 06.22.2025
In late May, several scientific organizations, including the International Society for Cell and Gene Therapy (ISCT), banded together to call for a 10-year moratorium on using CRISPR and related technologies to pursue human heritable germline editing. The declaration also outlined...
By Antonio Regalado, MIT Technology Review | 06.05.2025
Brian Armstrong, the billionaire CEO of the cryptocurrency exchange Coinbase, says he’s ready to fund a US startup focused on gene-editing human embryos. If he goes forward, it would be the first major commercial investment in one of medicine’s most...